These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Interleukin-8 during peritonitis in patients treated with CAPD; an in-vivo model of acute inflammation. Zemel D, Krediet RT, Koomen GC, Kortekaas WM, Geertzen HG, ten Berge RJ. Nephrol Dial Transplant; 1994; 9(2):169-74. PubMed ID: 8190331 [Abstract] [Full Text] [Related]
3. Dialysate markers of peritoneal tissue during peritonitis and in stable CAPD. Pannekeet MM, Zemel D, Koomen GC, Struijk DG, Krediet RT. Perit Dial Int; 1995; 15(6):217-25. PubMed ID: 7578497 [Abstract] [Full Text] [Related]
4. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis. Choi KC, Jeong TK, Lee SC, Kim SW, Kim NH, Lee KY. Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719 [Abstract] [Full Text] [Related]
5. Intraperitoneal nitric oxide production in patients treated by continuous ambulatory peritonal dialysis. Davenport A, Fernando RL, Varghese Z. Blood Purif; 2004; 22(2):216-23. PubMed ID: 15044821 [Abstract] [Full Text] [Related]
7. Peritoneal dialysis effluent, cytokine levels, and peritoneal mesothelial cell viability in CAPD: a possible relationship. Carozzi S, Nasini MG, Ravera M, Sanna A, Tirotta A, Lamperi S. Adv Perit Dial; 1997; 13():7-12. PubMed ID: 9360642 [Abstract] [Full Text] [Related]
8. Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis. Zemel D, Koomen GC, Hart AA, ten Berge IJ, Struijk DG, Krediet RT. J Lab Clin Med; 1993 Dec; 122(6):686-96. PubMed ID: 8245688 [Abstract] [Full Text] [Related]
10. Interleukin-8 in chronic renal failure and dialysis patients. Nakanishi I, Moutabarrik A, Okada N, Kitamura E, Hayashi A, Syouji T, Namiki M, Ishibashi M, Zaid D, Tsubakihara Y. Nephrol Dial Transplant; 1994 Dec; 9(10):1435-42. PubMed ID: 7816257 [Abstract] [Full Text] [Related]
11. Analysis of inflammatory mediators and peritoneal permeability to macromolecules shortly before the onset of overt peritonitis in patients treated with CAPD. Zemel D, Betjes MG, Dinkla C, Struijk DG, Krediet RT. Perit Dial Int; 1995 Dec; 15(2):134-41. PubMed ID: 7612733 [Abstract] [Full Text] [Related]
12. Interleukin-6 and interleukin-8 in dialysate and serum from patients on continuous ambulatory peritoneal dialysis. Brauner A, Hylander B, Wretlind B. Am J Kidney Dis; 1993 Sep; 22(3):430-5. PubMed ID: 8372840 [Abstract] [Full Text] [Related]
17. Interleukin-10, interferon gamma, interleukin-2, and soluble interleukin-2 receptor alpha detected during peritonitis in the dialysate and serum of patients on continuous ambulatory peritoneal dialysis. Lu Y, Hylander B, Brauner A. Perit Dial Int; 1996 Sep; 16(6):607-12. PubMed ID: 8981529 [Abstract] [Full Text] [Related]
18. Serial peritoneal macrophage function studies in CAPD patients with peritonitis. Lin CY, Huang TP. Adv Perit Dial; 1990 Sep; 6():114-9. PubMed ID: 1982786 [Abstract] [Full Text] [Related]
19. Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis. Lai KN, Lai KB, Lam CW, Chan TM, Li FK, Leung JC. Am J Kidney Dis; 2000 Apr; 35(4):644-52. PubMed ID: 10739785 [Abstract] [Full Text] [Related]